Concepedia

Publication | Open Access

Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure

17

Citations

34

References

2021

Year

Abstract

ClinicalTrials.gov, identifier: NCT03579082.

References

YearCitations

Page 1